ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $192,000 | +2.1% | 30,000 | 0.0% | 0.01% | 0.0% |
| Q4 2015 | $188,000 | +7.4% | 30,000 | 0.0% | 0.01% | 0.0% |
| Q3 2015 | $175,000 | -29.4% | 30,000 | 0.0% | 0.01% | -28.6% |
| Q2 2015 | $248,000 | +0.4% | 30,000 | 0.0% | 0.01% | +16.7% |
| Q1 2015 | $247,000 | +19.9% | 30,000 | 0.0% | 0.01% | +20.0% |
| Q4 2014 | $206,000 | +27.2% | 30,000 | 0.0% | 0.01% | +25.0% |
| Q3 2014 | $162,000 | -15.2% | 30,000 | 0.0% | 0.00% | -20.0% |
| Q2 2014 | $191,000 | -21.1% | 30,000 | 0.0% | 0.01% | -16.7% |
| Q1 2014 | $242,000 | +18.0% | 30,000 | 0.0% | 0.01% | +20.0% |
| Q4 2013 | $205,000 | -62.9% | 30,000 | 0.0% | 0.01% | -66.7% |
| Q3 2013 | $552,000 | +5.1% | 30,000 | 0.0% | 0.02% | -6.2% |
| Q2 2013 | $525,000 | – | 30,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 12,000,000 | $96,720,000 | 33.30% |
| Opaleye Management Inc. | 1,670,000 | $13,460,000 | 9.94% |
| Slate Path Capital LP | 6,620,000 | $53,357,000 | 4.04% |
| Granite Point Capital Management, L.P. | 648,000 | $5,223,000 | 3.74% |
| Palo Alto Investors LP | 6,917,248 | $55,754,000 | 2.30% |
| Camber Capital Management LP | 3,000,000 | $24,180,000 | 1.90% |
| Geduld E E | 277,600 | $2,237,000 | 1.21% |
| Elk Creek Partners, LLC | 290,886 | $2,345,000 | 1.01% |
| SELZ CAPITAL LLC | 400,000 | $3,224,000 | 0.81% |
| GENERAL AMERICAN INVESTORS CO INC | 1,200,000 | $9,672,000 | 0.81% |